As of Jul 31
| -0.08 / -6.35%|
The 1 analysts offering 12-month price forecasts for Rock Creek Pharmaceuticals Inc have a median target of 50.00, with a high estimate of 50.00 and a low estimate of 50.00. The median estimate represents a +4,137.29% increase from the last price of 1.18.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.